Ileoprost may alleviate cholesterol emboli syndrome

Patients with cholesterol emboli syndrome---a progressive disease unresponsive to treatment---may benefit from intravenous ileoprost. In a research pointer on p 268, Elinav and colleagues report on how four patients improved after treatment with ileoprost. Most cyanotic lesions disappeared, renal function improved, and pain was dramatically reduced. The authors say that ileoprost should be started early to stabilise and reverse the clinical syndrome.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Research pointers: Improvement in cholesterol emboli syndrome after iloprost therapy
Eran Elinav, Tova Chajek-Shaul, and Mirella Stern
BMJ 2002 324: 268-269. [Extract] [Full Text] [PDF]

Access jobs at BMJ Careers
Whats new online at Student BMJ